# Xeris Pharmaceuticals, Inc. – FDA Inspection, Mar 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/xeris-pharmaceuticals-inc/6369c92b-4d9f-4708-84a3-90f803fa2001
Source feed: FDA_Inspections

> FDA inspection 1086592 of Xeris Pharmaceuticals, Inc., March 14, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1086592
- Company Name: Xeris Pharmaceuticals, Inc.
- Inspection Date: 2019-03-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1288372 - 2025-07-03
- FDA Inspection 1192023 - 2022-11-16

## Related Officers

- [Company Rep](https://www.keypedia.com/people/susan-d-yuscius/2facd4c5-591b-4391-a361-271f959fb52a)

Company: https://www.keypedia.com/companies/xeris-pharmaceuticals-inc/9cbcaba7-f788-4118-a53e-0134b660ffb5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
